German pharmaceutical giant Bayer to cut thousands of jobs and sell off businesses, after Monsanto deal
"The (plan) includes an intention to exit the Animal Health business, and to allocate the investment resources necessary to support Animal Health to our core businesses of Pharmaceuticals, Consumer Health and Crop Science. "
